LONG-TERM RHIGF-I TREATMENT IN CHILDREN WITH SHORT STATURE DUE TO GHIS

因 GHIS 导致身材矮小的儿童的长期 RHIGF-I 治疗

• 批准号: 7625499
• 负责人: LOUIS E UNDERWOOD
• 金额: $ 1.13万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7625499
• 关键词: Child; Computer Retrieval of Information on Scientific Projects Database; Daily; Funding; Grant; Growth; Human; Injection of therapeutic agent; Institution; Insulin-Like Growth Factor I; Laron Syndrome; Names; Pharmaceutical Preparations; Purpose; Recombinants; Research; Research Personnel; Resources; Safety; Source; Testing; Time; United States National Institutes of Health; improved; research study

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research study is to evaluate the safety and efficacy of an experimental drug named recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of short stature. The purpose of the study is to see if injections of rhIGF-I two times daily will cause improved growth in children with growth hormone insensitivity syndrome, and to test the long-term safety of rhIGF-I.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 这项研究的目的是评估称为重组人类胰岛素样生长因子I（RHIGF-I）的实验药物的安全性和功效，以治疗短身材。该研究的目的是查看对RHIGF-I的注射是否每天两次会导致患有生长激素不敏感综合征的儿童的增长，并测试RHIGF-I的长期安全性。